BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL, Nakayama T, Gyorke S, Cardounel AJ, Carnes CA. Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 2009;84:227-36. [PMID: 19567484 DOI: 10.1093/cvr/cvp216] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Long VP 3rd, Bonilla IM, Vargas-Pinto P, Nishijima Y, Sridhar A, Li C, Mowrey K, Wright P, Velayutham M, Kumar S, Lee NY, Zweier JL, Mohler PJ, Györke S, Carnes CA. Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling. Life Sci 2015;123:61-71. [PMID: 25596015 DOI: 10.1016/j.lfs.2014.12.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
2 Caldwell JC, Mamas MA. Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship. Heart Fail Rev. 2012;17:27-33. [PMID: 21103928 DOI: 10.1007/s10741-010-9204-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
3 Ware B, Bevier M, Nishijima Y, Rogers S, Carnes CA, Lacombe VA. Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters. Am J Physiol Regul Integr Comp Physiol 2011;301:R1300-6. [PMID: 21849635 DOI: 10.1152/ajpregu.00822.2010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
4 Vysotskaya Z, Chidipi B, Rodgers JL, Tang X, Samal E, Kolliputi N, Mohapatra S, Bennett ES, Panguluri SK. Elevated potassium outward currents in hyperoxia treated atrial cardiomyocytes. J Cell Physiol 2018;233:4317-26. [PMID: 29139549 DOI: 10.1002/jcp.26263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Long VP 3rd, Bonilla IM, Baine S, Glynn P, Kumar S, Schober K, Mowrey K, Weiss R, Lee NY, Mohler PJ, Györke S, Hund TJ, Fedorov VV, Carnes CA. Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated IKado. Life Sci 2020;240:117068. [PMID: 31751583 DOI: 10.1016/j.lfs.2019.117068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Sovari AA, Dudley SC Jr. Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation. Front Physiol 2012;3:311. [PMID: 22934062 DOI: 10.3389/fphys.2012.00311] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
7 Pathak R, Lau DH, Mahajan R, Sanders P. Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation. J Atr Fibrillation. 2013;6:986. [PMID: 28496919 DOI: 10.4022/jafib.986] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Molina CE, Abu-Taha IH, Wang Q, Roselló-Díez E, Kamler M, Nattel S, Ravens U, Wehrens XHT, Hove-Madsen L, Heijman J, Dobrev D. Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. Front Physiol 2018;9:1383. [PMID: 30356673 DOI: 10.3389/fphys.2018.01383] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
9 Severino P, D'Amato A, Pucci M, Infusino F, Birtolo LI, Mariani MV, Lavalle C, Maestrini V, Mancone M, Fedele F. Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels. Int J Mol Sci 2020;21:E3167. [PMID: 32365863 DOI: 10.3390/ijms21093167] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
10 Chan CS, Lin YK, Chen YC, Lu YY, Chen SA, Chen YJ. Heart Failure Differentially Modulates Natural (Sinoatrial Node) and Ectopic (Pulmonary Veins) Pacemakers: Mechanism and Therapeutic Implication for Atrial Fibrillation. Int J Mol Sci 2019;20:E3224. [PMID: 31262061 DOI: 10.3390/ijms20133224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Lu YY, Chen YC, Kao YH, Chen SA, Chen YJ. Extracellular matrix of collagen modulates arrhythmogenic activity of pulmonary veins through p38 MAPK activation. J Mol Cell Cardiol 2013;59:159-66. [PMID: 23524328 DOI: 10.1016/j.yjmcc.2013.03.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
12 Börschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases - Myocardial infarction and heart failure - A cause for concern. Int J Cardiol 2019;287:162-73. [PMID: 30528622 DOI: 10.1016/j.ijcard.2018.11.123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rochette L, Tatou E, Maupoil V, Zeller M, Cottin Y, Jazayeri S, Brenot R, Girard C, David M, Vergely C. Atrial and vascular oxidative stress in patients with heart failure. Cell Physiol Biochem 2011;27:497-502. [PMID: 21691067 DOI: 10.1159/000329951] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
14 Svoboda LK, Reddie KG, Zhang L, Vesely ED, Williams ES, Schumacher SM, O'Connell RP, Shaw R, Day SM, Anumonwo JM, Carroll KS, Martens JR. Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5. Circ Res 2012;111:842-53. [PMID: 22843785 DOI: 10.1161/CIRCRESAHA.111.263525] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
15 Fu H, Li G, Liu C, Li J, Cheng L, Yang W, Tse G, Zhao J, Liu T. Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model. Oncotarget 2016;7:83850-8. [PMID: 27863381 DOI: 10.18632/oncotarget.13339] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Peigh G, Shah SJ, Patel RB. Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets. Curr Heart Fail Rep 2021;18:85-98. [PMID: 33864224 DOI: 10.1007/s11897-021-00510-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Husti Z, Varró A, Baczkó I. Arrhythmogenic Remodeling in the Failing Heart. Cells 2021;10:3203. [PMID: 34831426 DOI: 10.3390/cells10113203] [Reference Citation Analysis]
18 Choi S, Baudot M, Vivas O, Moreno CM. Slowing down as we age: aging of the cardiac pacemaker's neural control. Geroscience 2021. [PMID: 34292477 DOI: 10.1007/s11357-021-00420-3] [Reference Citation Analysis]
19 Sturm AC, Kline CF, Glynn P, Johnson BL, Curran J, Kilic A, Higgins RS, Binkley PF, Janssen PM, Weiss R, Raman SV, Fowler SJ, Priori SG, Hund TJ, Carnes CA, Mohler PJ. Use of whole exome sequencing for the identification of Ito-based arrhythmia mechanism and therapy. J Am Heart Assoc 2015;4:e001762. [PMID: 26015324 DOI: 10.1161/JAHA.114.001762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P, Weiss JN, Cai H. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol 2013;62:72-9. [PMID: 23643589 DOI: 10.1016/j.yjmcc.2013.04.019] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 12.7] [Reference Citation Analysis]
21 Lou Q, Hansen BJ, Fedorenko O, Csepe TA, Kalyanasundaram A, Li N, Hage LT, Glukhov AV, Billman GE, Weiss R, Mohler PJ, Györke S, Biesiadecki BJ, Carnes CA, Fedorov VV. Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping. Circulation 2014;130:315-24. [PMID: 24838362 DOI: 10.1161/CIRCULATIONAHA.113.007086] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
22 Yang B, Li C, Sun J, Wang X, Liu X, Yang C, Chen L, Zhou J, Hu H. Inhibition of potassium currents is involved in antiarrhythmic effect of moderate ethanol on atrial fibrillation. Toxicology and Applied Pharmacology 2017;322:89-96. [DOI: 10.1016/j.taap.2017.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
23 Rossato LG, Costa VM, de Pinho PG, Carvalho F, de Lourdes Bastos M, Remião F. Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes. Arch Toxicol 2011;85:929-39. [DOI: 10.1007/s00204-010-0630-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
24 Ling LH, Kistler PM, Kalman JM, Schilling RJ, Hunter RJ. Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol 2016;13:131-47. [PMID: 26658575 DOI: 10.1038/nrcardio.2015.191] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
25 van der Schoor L, van Hattum EJ, de Wilde SM, Harlianto NI, van Weert AJ, Bloothooft M, van der Heyden MAG. Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease. Int J Mol Sci 2020;21:E5746. [PMID: 32796537 DOI: 10.3390/ijms21165746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Adameova A, Shah AK, Dhalla NS. Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias. Int J Mol Sci 2020;21:E4200. [PMID: 32545595 DOI: 10.3390/ijms21124200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Lappegård KT, Hovland A, Pop GA, Mollnes TE. Atrial fibrillation: inflammation in disguise? Scand J Immunol 2013;78:112-9. [PMID: 23672430 DOI: 10.1111/sji.12061] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
28 Qin D, Mansour MC, Ruskin JN, Heist EK. Atrial Fibrillation–Mediated Cardiomyopathy. Circ: Arrhythmia and Electrophysiology 2019;12. [DOI: 10.1161/circep.119.007809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
29 Kettlewell S, Burton FL, Smith GL, Workman AJ. Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res 2013;99:215-24. [PMID: 23568957 DOI: 10.1093/cvr/cvt087] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
30 Lau DH, Psaltis PJ, Mackenzie L, Kelly DJ, Carbone A, Worthington M, Nelson AJ, Zhang Y, Kuklik P, Wong CX, Edwards J, Saint DA, Worthley SG, Sanders P. Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: remodeling of the same sort. J Cardiovasc Electrophysiol 2011;22:175-82. [PMID: 20662987 DOI: 10.1111/j.1540-8167.2010.01851.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
31 Zhao N, Li Q, Zhang K, Wang K, He R, Yuan Y, Zhang H. Heart failure-induced atrial remodelling promotes electrical and conduction alternans. PLoS Comput Biol 2020;16:e1008048. [PMID: 32658888 DOI: 10.1371/journal.pcbi.1008048] [Reference Citation Analysis]
32 Gai X, Zhang Z, Liang Y, Chen Z, Yang X, Hou J, Lan X, Zheng W, Hou J, Huang M. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Clinica Chimica Acta 2010;411:719-24. [DOI: 10.1016/j.cca.2010.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
33 Bonilla IM, Sridhar A, Nishijima Y, Györke S, Cardounel AJ, Carnes CA. Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology. J Cardiovasc Pharmacol 2013;61:401-7. [PMID: 23364607 DOI: 10.1097/FJC.0b013e31828748ca] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
34 Smith SA, Hughes LD, Kline CF, Kempton AN, Dorn LE, Curran J, Makara M, Webb TR, Wright P, Voigt N, Binkley PF, Janssen PM, Kilic A, Carnes CA, Dobrev D, Rasband MN, Hund TJ, Mohler PJ. Dysfunction of the β2-spectrin-based pathway in human heart failure. Am J Physiol Heart Circ Physiol 2016;310:H1583-91. [PMID: 27106045 DOI: 10.1152/ajpheart.00875.2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
35 Rankin AC, Workman AJ. Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res 2009;84:180-1. [PMID: 19713283 DOI: 10.1093/cvr/cvp299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
36 Zhang L, Liu Q, Liu C, Zhai X, Feng Q, Xu R, Cui X, Zhao Z, Cao J, Wu B. Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes. Sci China Life Sci 2013;56:788-96. [PMID: 23929001 DOI: 10.1007/s11427-013-4531-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
37 van der Heyden MA, Sánchez-Chapula JA. Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way. Heart Rhythm 2011;8:1076-80. [PMID: 21296684 DOI: 10.1016/j.hrthm.2011.01.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
38 Ziolo MT, Mohler PJ. Defining the role of oxidative stress in atrial fibrillation and diabetes. J Cardiovasc Electrophysiol 2015;26:223-5. [PMID: 25298131 DOI: 10.1111/jce.12560] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
39 Workman AJ, Smith GL, Rankin AC. Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther 2011;131:221-41. [PMID: 21334377 DOI: 10.1016/j.pharmthera.2011.02.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
40 Denham NC, Pearman CM, Caldwell JL, Madders GWP, Eisner DA, Trafford AW, Dibb KM. Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure. Front Physiol 2018;9:1380. [PMID: 30337881 DOI: 10.3389/fphys.2018.01380] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
41 Stokes MB, Sanders P. Does Left Ventricular Systolic Function Matter? Treating Atrial Fibrillation in HFrEF Versus HFpEF. Cardiol Clin 2019;37:157-66. [PMID: 30926017 DOI: 10.1016/j.ccl.2019.01.008] [Reference Citation Analysis]
42 Brown SM, Larsen NK, Thankam FG, Agrawal DK. Fetal cardiomyocyte phenotype, ketone body metabolism, and mitochondrial dysfunction in the pathology of atrial fibrillation. Mol Cell Biochem 2021;476:1165-78. [PMID: 33188453 DOI: 10.1007/s11010-020-03980-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Pandit SV, Workman AJ. Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure. Clin Med Insights Cardiol 2016;10:41-6. [PMID: 27812293 DOI: 10.4137/CMC.S39713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Patel RB, Vaduganathan M, Shah SJ, Butler J. Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics. Pharmacol Ther 2017;176:32-9. [PMID: 27773787 DOI: 10.1016/j.pharmthera.2016.10.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
45 Bonilla IM, Long VP 3rd, Vargas-Pinto P, Wright P, Belevych A, Lou Q, Mowrey K, Yoo J, Binkley PF, Fedorov VV, Györke S, Janssen PM, Kilic A, Mohler PJ, Carnes CA. Calcium-activated potassium current modulates ventricular repolarization in chronic heart failure. PLoS One 2014;9:e108824. [PMID: 25271970 DOI: 10.1371/journal.pone.0108824] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
46 Nishijima Y, Sridhar A, Bonilla I, Velayutham M, Khan M, Terentyeva R, Li C, Kuppusamy P, Elton TS, Terentyev D, Györke S, Zweier JL, Cardounel AJ, Carnes CA. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res 2011;91:71-9. [PMID: 21460065 DOI: 10.1093/cvr/cvr087] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
47 Gao G, Xie A, Zhang J, Herman AM, Jeong EM, Gu L, Liu M, Yang KC, Kamp TJ, Dudley SC. Unfolded protein response regulates cardiac sodium current in systolic human heart failure. Circ Arrhythm Electrophysiol 2013;6:1018-24. [PMID: 24036084 DOI: 10.1161/CIRCEP.113.000274] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
48 Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014;114:1483-1499. [PMID: 24763466 DOI: 10.1161/circresaha.114.302226] [Cited by in Crossref: 356] [Cited by in F6Publishing: 187] [Article Influence: 44.5] [Reference Citation Analysis]